CMAXQ — Caremax Income Statement
0.000.00%
- $0.00m
- $388.68m
- $751.10m
- 24
- 62
- 42
- 39
Annual income statement for Caremax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-Q | 10-K/A | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 296 | 631 | 751 |
Cost of Revenue | |||||
Gross Profit | — | — | 31.4 | 80.3 | 13.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | — | 4.01 | 317 | 673 | 1,387 |
Operating Profit | 0 | -4.01 | -21.4 | -42 | -636 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | — | -21.5 | -6.52 | -57.3 | -684 |
Provision for Income Taxes | |||||
Net Income After Taxes | — | -21.5 | -6.68 | -37.8 | -683 |
Net Income Before Extraordinary Items | |||||
Net Income | — | -21.5 | -6.68 | -37.8 | -683 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0 | -21.5 | -6.67 | -37.8 | -683 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | — | -36.2 | -5.97 | -9.69 | -90.1 |